Article 51 in France: How to Use the Country’s SUPER weapon for Real-World Health Innovation

by Odelle Technology

Article 51 of the Loi de Financement de la Sécurité Sociale (LFSS 2018) is the most flexible, strategic, and scientifically grounded mechanism France has created to transform care delivery using real-world experimentation rather than theoretical policy reform.

Instead of waiting for national codes to adapt (NGAP, CCAM, GHS, T2A), Article 51 allows local actors to redesign care pathways, deploy new funding models, test digital platforms, and temporarily reimburse activities that are not yet recognised in the national tariff system.

If used correctly, it becomes a fast track for innovation, a policy laboratory, and often the stepping stone to national reimbursement.

What Article 51 Actually Does

Article 51 authorises time-limited pilots (2–5 years) that test new clinical, organisational, or financial models. These pilots operate with:

  • Derogatory funding rules
    – activities not reimbursed in NGAP or CCAM can be financed
    – alternative models (bundled payments, forfaits, capitation, shared savings)
  • Protected budgets
    via the Fonds d’Innovation du Système de Santé (FISS) and regional funds (FIR).
  • National evaluation
    conducted with HTA-aligned methodologies (realist evaluation, RWE, mixed methods).

Article 51 is not a research programme.
It is a system reform tool, designed to test models that could become routine practice.

Who Can Apply

Applications are open to nearly every actor in the ecosystem:

  • ARS (regional health authorities)
  • Hospital groups (GHT)
  • CHU, CH, CLCC
  • GP networks & MSPs
  • Non-profits and associations
  • Start-ups working with health providers
  • Federations, CRUQPC, clinical societies

The crucial rule: projects must be submitted with a health provider, not solely by an industrial innovator.

How the Application Process Works

Step 1 — Letter of Intent (Lettre d’intention)

2–4 pages explaining:

  • the problem
  • the innovation (clinical, organisational, financial)
  • expected impact
  • target population & region
  • why Article 51 is required (derogation, financing needs)

Step 2 — Full Proposal

Co-signed with partners, including:

  • clinical pathway redesign
  • financial model (forfait, bundled payment, episode-based, capitation…)
  • cost impact & projected budget
  • KPIs (quality, safety, utilisation, economics, equity)
  • governance & technical infrastructure
  • RWE and evaluation framework

Step 3 — National Review

Evaluated by:

  • Ministry of Health
  • CNAM
  • Comité Technique de l’Innovation en Santé (CTIS)

Step 4 — Pilot Launch

Funding allocated for 2–5 years.
Derogatory reimbursement begins immediately.

Step 5 — Evaluation

Mid-term + final evaluation using:

  • realist methodologies
  • RWE-based impact measurement
  • mixed quantitative–qualitative evidence

Step 6 — Decision

The Ministry and CNAM choose to:

  • generalise the model nationally,
  • extend the pilot,
  • modify it,
  • or terminate.

Generalisation often leads to new CCAM/NGAP codes or new forfaits.

What Article 51 Finances

Unlike traditional act-based reimbursement, Article 51 allows:

✔ Bundled payments

For complete pathways (e.g., bariatric surgery, oncology episodes, dementia).

✔ Flat-rate (forfait) packages

For prevention, follow-up, coordination, case management.

✔ Non-tariffed professionals

psychomotricians, neuropsychologists, occupational therapists, dieticians.

✔ Digital platforms & coordination systems

Including tele-expertise, patient navigation, shared dashboards.

✔ Integrated care models

Health–social care, chronically ill populations, frailty pathways.

Examples of Article 51 Pilots

A. SLDD Occitanie — Universal Access to Neurodevelopmental Diagnostics

  • Age 6–15
  • Free access to neuropsychology, occupational therapy, psychomotricity
  • €21M funded through FISS + FIR
  • Evaluation by REES France
  • Structured pathway aligned with HAS TSLA guidelines
  • Seamless integration with Ma Santé 2022

This project eliminates out-of-pocket costs that previously blocked diagnosis for many families.

B. Obepar — A Bundled Payment for Bariatric Surgery (Île-de-France)

60,000 bariatric surgeries/year in France, but national guidelines for pre-/post-operative care are inconsistently followed.

Key problems:

  • poor coordination hospital ↔ community
  • non-reimbursed assessments (psychology, dietetics)
  • long-term complications
  • loss to follow-up

Obepar (four CSOs in Île-de-France) introduces:

  • a single forfait covering all pre & post-op steps
  • reimbursement of currently non-tariffed professionals
  • a coordination hub to reduce loss to follow-up
  • recruitment of 2,000 patients over 5 years
  • validated by the ARS & Ministry
  • designed for national scale-up if efficient

How Organisations Can Use Article 51

If you are a hospital or GHT:

  • Redesign a pathway with unmet needs
  • Integrate digital tools (navigation, tele-monitoring, triage)
  • Build a bundled-payment model
  • Add currently non-reimbursed professionals

If you are a start-up:

You cannot lead—but you can:

  • partner with providers
  • integrate into pathway redesign
  • obtain temporary reimbursement for your activity
  • generate real-world evidence for HAS/HTA

If you are an ARS:

  • Identify regional inequities
  • Propose large-scale population pilots
  • Coordinate cross-sector integration (health–social care)

Why Article 51 is Becoming a Model for Europe

1. Real-World Evidence Becomes Central

Evaluators use realist science (“what works, for whom, under what conditions”), not RCT-only logic.

2. Financing Follows the Pathway, Not the Procedure

A shift from act-based to value-based reimbursement.

3. National Scalability

Successful pilots become:

  • new CCAM/NGAP codes
  • new forfaits
  • new integrated pathways

4. Equity at the Core

Projects like SLDD Occitanie remove financial barriers entirely.

How to Start a Successful Article 51 Project — A Practical Checklist

Essentials for Success:

  • A clearly defined population
  • A broken or inefficient current pathway
  • Evidence-based redesign (aligned with HAS)
  • A strong economic model (cost + avoided costs + outcomes)
  • A coordination mechanism (digital or organisational)
  • KPIs for clinical, financial, and operational impact
  • A credible evaluation partner (REES, research units, universities)

Documents You Will Need:

  • Lettre d’intention
  • Full project dossier (clinical + financial + pathway + RWE)
  • Budget impact analysis
  • Evaluation plan
  • Partner agreements
  • Governance plan
  • Deployment roadmap

References

1. Foundational Legal & Policy Documents

2. Evaluation Science, Realist Methodology & Real-World Evidence

3. SLDD / TSLA Occitanie (Neurodevelopmental Pathway)

4. Obepar – Bariatric Surgery Bundled Payment Pilot

5. National Overviews & Official Reports

6. Additional High-Quality Context Sources

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but if you require more information click the 'Read More' link Accept Read More